Research peptide
Batch analytics · >99 % purity
Illustrative image; appearance and packaging may vary. 10 unlabelled vials, labelled only on the kit packaging. The selected strength applies.
No reviews yet. Be the first to share your experience.
Research Use Only (RUO)
Tier I · Synthesis QC
Tier I · Synthesis QC
In-house · per step
RP-HPLC, MS confirmation, sequence verification in cleanroom.
Tier II · In-process
Tier II · In-process
Batch · final
Identity, purity, and assay before release.
Tier III · Third-party lab
Tier III · Third-party lab
External · independent
HPLC, ICP-MS, and microbiology by accredited lab.
953
satisfied
99.41%
Avg. purity 2026
4.8 ★
Store rating
| Molecule | TB-500 + BPC-157 Blend |
| Composition per vial | 5 + 5 mg, 10 + 10 mg |
| Form | Lyophilized powder, single vial |
| Box contents | 10 vials of identical composition |
| Purity per component | ≥99 % (HPLC) |
This blend brings TB-500 and BPC-157 together in a single vial. TB-500 is discussed as an actin-binding fragment of thymosin beta-4 associated with cell migration and cytoskeletal dynamics, while BPC-157 is discussed in repair and angiogenesis models. Both components are described independently of each other in the in-vitro literature. Providing them together supports experimental series that examine both profiles side by side in the same test system. The lyophilized format keeps both peptides in one vial and simplifies the setup of comparable assays. Researchers who buy TB-500 BPC-157 use this 10-vial kit as a defined reference for in-vitro work.
The lyophilized powder is reconstituted in the laboratory immediately before use with a suitable sterile solvent. The resulting solution is processed promptly and protected from direct light during handling. Volume and concentration details follow the experimental plan of the performing institution; this data sheet makes no specifications on that point. Clean working practice with calibrated pipettes and consumption within a single experimental series support the reproducibility of results.
This blend is used in in-vitro research as a defined reference material for combined questions. Typical applications include cell migration and cytoskeleton assays, models of tissue repair and angiogenesis models in which migration, adhesion and proliferation parameters of cells are recorded. The uniform composition of both components makes the blend a reproducible reference point for comparison series and positive controls in controlled experimental setups. This allows dose series and control approaches to be built on an identical starting basis.
Every batch is tested; both components reach at least ≥99 % by HPLC. A complementary identity test confirms the sequence of TB-500 and BPC-157. Testing is performed per batch and applies uniformly to all vials in a box; the results are recorded for each batch. Deviations from the specified values would be documented and reviewed before a batch is released. Uniform documentation supports traceability across all vials in a box.
Available amounts per vial: 5 + 5 mg, 10 + 10 mg. Box of 10 vials.
Every batch is analyzed by an independent laboratory via HPLC before shipment. We document purity (avg. 99.41% in 2026), mass spectrometry identity, and sterility. Production follows GMP standards in ISO-certified laboratories.
For research use only. Not for human or animal use, diagnosis, therapy or consumption.
A box contains exactly 10 identical, unlabelled vials of the selected variant. The product label is on the outer box.
Available amounts per vial: 5 + 5 mg, 10 + 10 mg.
5-Amino-1MQ
AHK-Cu
AOD-9604
B12
BAC Water 10 ml
BPC-157
Cagrilintide 5 mg
CJC-1295 (Mod GRF 1-29)
